Pencil Biosciences Seed
pencilbiosciences.com
Cell & Gene Therapy
Biotechnology
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Oct 2023 · 3 yr ago
Grants
$1.2M
3 grants · CORDIS
Backers
2
Future Planet Capital, Octopus Ventures
The money's age
Long since its last round
36 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 11, 2023
Raised a round Venture round
May 1, 2023
Won a grant $870k · CORDIS
Jun 1, 2020
Won a grant $92k · CORDIS
Feb 13, 2020
Raised a round Venture round
Nov 13, 2019
Raised a round Venture round
Nov 1, 2019
Won a grant $250k · CORDIS
Nov 5, 2018
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | May 2023 | $870k | — | CORDIS |
| Grant | Jun 2020 | $92k | — | CORDIS |
| Venture round | Feb 2020 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Nov 2019 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Nov 2019 | $250k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | PENCIL BIOSCIENCES LIMITED | Companies House |
| Registered | 5 Nov 2018 |
Backed byfrom the funds' portfolios and accelerator catalogs
Future Planet Capital 
Octopus Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.
Horizon Discovery drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical…
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Stately Bio is developing the next generation of life-saving regenerative medicines with the world.
News
Pencil Biosciences Appoints Jonathan Thon, PhD, as Chair of the Board of Directors
Cheshire, UK - September 15, 2025 - Pencil Biosciences, a biotech company pioneering a new class of gene editor, today announced the appointment of Jonathan Thon, PhD, as the new Chair of its Board of Directors. The company's novel platform, which offers
Read more
Report
Pencil Biosciences completes fundraise to develop novel gene editing and modulation technology
Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have impact across a wide range of applications, including new therapeutic options for patients with rare diseases and cancer. Pencil Biosciences is developi
Read more
Report
Investors write £5.6m cheque to Pencil Biosciences
Pencil Biosciences has secured £5.6m in seed financing for its gene modulation technology that has applications in treating diseases like cancer. Based at Alderley Park, Cheshire, the startup is developing gene editing technology that has applications in
Read more
Report
Pencil Biosciences awarded Innovate UK Investor Partnership grant
Pencil Biosciences awarded Innovate UK Investor Partnership grant Pencil Biosciences, a UK-based biotech company, announces it has been awarded a grant of £7000,000 from Innovate UK. The grant will fund a project to create a synthetic gene editing system
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Macclesfield
United Kingdom
HQ
Financials
Total raised
$1.2M
Latest round
Venture - Series Unknown
Funding rounds
6